News
PRNewswire/ -- mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, is pleased to ...
51m
Woman's World on MSNNew GLP-1 Called MariTide Shows 20% Weight Loss-Without a PlateauIn the same way weight varies from person to person, so do the best weight loss strategies. While some people succeed with ...
Cohen Investment Advisors LLC just took a massive leap into Amgen, increasing its holdings by a jaw-dropping 2,700%. The firm ...
Eli Lilly and Novo Nordisk, which already have approved GLP-1 weight loss drugs that are raking in billions of revenues, have ...
14hon MSN
Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the following day. Its shares closed the trading session more than 4% ...
The Dow Jones Industrial Average is rallying Tuesday afternoon with shares of Amgen and Merck delivering the strongest returns for the blue-chip average.
Buoyed by positive gains for shares of Amgen and Merck, the Dow Jones Industrial Average is climbing Tuesday morning. Supported by world-class markets data from Dow Jones and FactSet, and partnering ...
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with significant health benefits.
Detroit Lions legend Barry Sanders has let a terrifying personal experience guide him to advocate for a very important cause ...
Thanks to his trusty Dexcom continuous glucose monitor (CGM), former boy band star Lance Bass is saying “bye bye bye” to ...
In a detail-thin announcement, Amgen said that adding bemarituzumab to chemotherapy improved overall survival, though ...
Amgen's Phase 3 trial of bemarituzumab plus chemo met its survival goal in FGFR2b+ gastric cancer, with full data expected ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results